Abstract
Older patients with AML face difficult treatment decisions as they can be treated either with ‘intensive’ chemotherapy requiring prolonged hospitalization, or ‘non-intensive’ chemotherapy. Although clinicians often perceive intensive chemotherapy as more burdensome, research is lacking on patients’ quality of life (QOL) and psychological distress. We conducted a longitudinal study of older patients (≥60 years) newly diagnosed with AML receiving intensive (cytarabine/anthracycline combination) or non-intensive (hypomethylating agents) chemotherapy. We assessed patients’ QOL [Functional-Assessment-of-Cancer-Therapy-Leukemia] and psychological distress [Hospital-Anxiety-and-Depression-Scale] at baseline and 2, 4, 8, 12, and 24 weeks after diagnosis. We enrolled 75.2% (100/133) of eligible patients within 72-hours of initiating intensive (n = 50) or non-intensive (n = 50) chemotherapy. Patient QOL improved over time (β = 0.32, P = 0.013). At baseline, 33.3% (33/100) and 30.0% (30/100) of patients reported clinically significant depression and anxiety symptoms, respectively, with no differences between groups. Patients’ depression symptoms did not change over time, while their anxiety symptoms decreased over time (β = −0.08, P < 0.001). Patient-reported QOL, depression and anxiety symptoms did not differ significantly at any time point between those who received intensive versus non-intensive chemotherapy. Older patients with AML experience improvements in their QOL and anxiety while undergoing treatment. Patients receiving intensive and non-intensive chemotherapy have similar QOL and mood trajectories.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE, et al. Age and acute myeloid leukemia. Blood. 2006;107:3481–5. https://doi.org/10.1182/blood-2005-09-3724
Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. J Clin Oncol. 2007;25:1908–15. https://doi.org/10.1200/JCO.2006.10.2731
Dombret H, Raffoux E, Gardin C. Acute myeloid leukemia in the elderly. Semin Oncol. 2008;35:430–8. https://doi.org/10.1053/j.seminoncol.2008.04.013
Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–74. https://doi.org/10.1182/blood-2009-07-235358
Kantarjian HM, Thomas XG, Dmoszynska A, Wierzbowska A, Mazur G, Mayer J, et al. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol. 2012;30:2670–7. https://doi.org/10.1200/JCO.2011.38.9429
Lubbert M, Suciu S, Baila L, Ruter BH, Platzbecker U, Giagounidis A, et al. Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group. J Clin Oncol. 2011;29:1987–96. https://doi.org/10.1200/JCO.2010.30.9245
Sekeres MA, Stone RM, Zahrieh D, Neuberg D, Morrison V, De Angelo DJ, et al. Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia. 2004;18:809–16. https://doi.org/10.1038/sj.leu.2403289
El-Jawahri, AR et al. Health care utilization and end-of-life care for older patients with acute myeloid leukemia. Cancer. 2015; https://doi.org/10.1002/cncr.29430
Rogers BB. Advances in the management of acute myeloid leukemia in older adult patients. Oncol Nurs Forum. 2010;37:E168–79. https://doi.org/10.1188/10.ONF.E168-E179
Storey S, Gray TF, Bryant AL. Comorbidity, physical function, and quality of life in older adults with acute myeloid. Leuk Curr Geriatr Rep. 2017;6:247–54. https://doi.org/10.1007/s13670-017-0227-8
Buckley SA, Kirtane K, Walter RB, Lee SJ, Lyman GH. Patient-reported outcomes in acute myeloid leukemia: Where are we now? Blood Rev. 2018;32:81–87. https://doi.org/10.1016/j.blre.2017.08.010
Alibhai SM, Leach M, Kermalli H, Gupta V, Kowgier ME, Tomlinson GA, et al. The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults. Crit Rev Oncol/Hematol. 2007;64:19–30. https://doi.org/10.1016/j.critrevonc.2007.07.003
Hudson, P Positive aspects and challenges associated with caring for a dying relative at home. Int J Palliat Nurs. 2004;10:58–65. discussion 65. https://doi.org/10.12968/ijpn.2004.10.2.12454
Proot IM, Abu-Saad HH, ter Meulen RH, Goldsteen M, Spreeuwenberg C, Widdershoven GA. The needs of terminally ill patients at home: directing one’s life, health and things related to beloved others. Palliat Med. 2004;18:53–61.
El-Jawahri AR, Traeger LN, Kuzmuk K, Eusebio JR, Vandusen HB, Shin JA, et al. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation. Cancer. 2015;121:951–9. https://doi.org/10.1002/cncr.29149
Given B, Wyatt G, Given C, Sherwood P, Gift A, DeVoss D, et al. Burden and depression among caregivers of patients with cancer at the end of life. Oncol Nurs Forum. 2004;31:1105–17. https://doi.org/10.1188/04.ONF.1105-1117
Harding R, Higginson IJ. What is the best way to help caregivers in cancer and palliative care? A systematic literature review of interventions and their effectiveness. Palliat Med. 2003;17:63–74.
McCorkle R, Siefert ML, Dowd MF, Robinson JP, Pickett M. Effects of advanced practice nursing on patient and spouse depressive symptoms, sexual function, and marital interaction after radical prostatectomy. Urol Nurs. 2007;27:65–77. discussion 8–80.
Northouse LL, Mood D, Templin T, Mellon S, George T. Couples’ patterns of adjustment to colon cancer. Social Sci & Med. 2000;50:271–84.
Lau DT, Berman R, Halpern L, Pickard AS, Schrauf R, Witt W. Exploring factors that influence informal caregiving in medication management for home hospice patients. J Palliat Med. 2010;13:1085–90. https://doi.org/10.1089/jpm.2010.0082
Fife BL, Monahan PO, Abonour R, Wood LL, Stump TE. Adaptation of family caregivers during the acute phase of adult BMT. Bone Marrow Transplant. 2009;43:959–66. https://doi.org/10.1038/bmt.2008.405
Siston AK, List MA, Daugherty CK, Banik DM, Menke C, Cornetta K, et al. Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;27:1181–8. https://doi.org/10.1038/sj.bmt.1703059
Foxall MJ, Gaston-Johansson F. Burden and health outcomes of family caregivers of hospitalized bone marrow transplant patients. J Adv Nurs. 1996;24:915–23.
Cella D, Jensen SE, Webster K, Hongyan D, Lai JS, Rosen S, et al. Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy--Leukemia (FACT-Leu) questionnaire. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes. Research. 2012;15:1051–8. https://doi.org/10.1016/j.jval.2012.08.2210
Santana MJ, Au HJ, Dharma-Wardene M, Hewitt JD, Dupere D, Hanson J, et al. Health-related quality of life measures in routine clinical care: can FACT-fatigue help to assess the management of fatigue in cancer patients? Int J Technol Assess Health Care. 2009;25:90–96.
Mohamedali H, Breunis H, Timilshina N, Brandwein JM, Gupta V, Minden MD, et al. Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia. Leuk Res. 2012;36:1241–8. https://doi.org/10.1016/j.leukres.2012.05.020
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J General Intern Med. 2001;16:606–13.
Stone M. Acute Myeloid Leukemia in First Remission: To Choose Transplantation or Not? J Clin Oncol. 2012;21:1262–6.
Klepin HD. Elderly acute myeloid leukemia: assessing risk. Curr Hematol Malig Rep. 2015;10:118–25. https://doi.org/10.1007/s11899-015-0257-2
Alibhai SM, Breunis H, Timilshina N, Brignardello-Petersen R, Tomlinson G, Mohamedali H, et al. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age. J Geriatr Oncol. 2015;6:262–71. https://doi.org/10.1016/j.jgo.2015.04.002
Kayastha N, Wolf SP, Locke SC, Samsa GP, El-Jawahri A, LeBlanc TW. The impact of remission status on patients’ experiences with acute myeloid leukemia (AML): an exploratory analysis of longitudinal patient-reported outcomes data. Support Care Cancer. 2018;26:1437–45. https://doi.org/10.1007/s00520-017-3973-4
Beattie S, Lebel S. The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: a comprehensive literature review. Psycho-Oncol. 2011;20:1137–50. https://doi.org/10.1002/pon.1962
Gemmill R, Cooke L, Williams AC, Grant M. Informal caregivers of hematopoietic cell transplant patients: a review and recommendations for interventions and research. Cancer Nurs. 2011;34:E13–21. https://doi.org/10.1097/NCC.0b013e31820a592d
Dionne-Odom JN, Azuero A, Lyons KD, Hull JG, Tosteson T, Li Z, et al. Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial. J Clin Oncol: Off J Am Soc Clin Oncol. 2015;33:1446–52. https://doi.org/10.1200/JCO.2014.58.7824
El-Jawahri, A Greer JA, Pirl WF, Park ER, Jackson VA, Back AL, et al. Effects of early integrated palliative care on caregivers of patients with lung and gastrointestinal cancer: a randomized clinical trial. The oncologist. 2017. https://doi.org/10.1634/theoncologist.2017-0227
Acknowledgements
This work was supported by funds from the National Cancer Institute Federal Share Program (El-Jawahri), and K24 CA 181253 (Temel).
Author information
Authors and Affiliations
Contributions
Dr. El-Jawahri had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: El-Jawahri, Traeger, Abel, Steensma, Stone, Temel, and Greer. Acquisition of data: El-Jawahri, Waldman, VanDusen, Abel, Fathi, Steensma DeAngelo, Wadleigh, Hobbs, Foster, Brunner, Amrein, Stone, Temel, and Greer. Analysis and interpretation of data: El-Jawahri, Traeger, Waldman, VanDusen, Abel, Fathi, Steensma, LeBlanc, Horick, DeAngelo, Wadleigh, Hobbs, Foster, Brunner, Amrein, Stone, Temel, and Greer. Drafting of the manuscript: El-Jawahri, Abel, Steensma, Stone, Temel, and Greer. Critical revision of the manuscript for important intellectual content: El-Jawahri, Traeger, Waldman, VanDusen, Abel, Fathi, Steensma, LeBlanc, Horick, DeAngelo, Wadleigh, Hobbs, Foster, Brunner, Amrein, Stone, Temel, and Greer. Statistical analysis: El-Jawahri, Horick. Obtained funding: El-Jawahri. Administrative, technical, or material support: Waldman, VanDusen. Study supervision: El-Jawahri, Temel, and Greer.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
El-Jawahri, A., Abel, G.A., Traeger, L. et al. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy. Leukemia 33, 2393–2402 (2019). https://doi.org/10.1038/s41375-019-0449-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-019-0449-1
This article is cited by
-
Single nucleotide polymorphisms conferring susceptibility to leukemia and oral mucositis: a multi-center pilot study of patients prior to conditioning therapy for hematopoietic cell transplant
Supportive Care in Cancer (2024)
-
Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence
Current Treatment Options in Oncology (2023)
-
Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia
Cancer Immunology, Immunotherapy (2022)
-
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Blood Cancer Journal (2022)
-
Quality of life among cancer inpatients 80 years and older: a systematic review
Health and Quality of Life Outcomes (2021)